Predicting unresectability in pancreatic cancer patients: The additive effects of CT and endoscopic ultrasound

Journal of Gastrointestinal Surgery

Volumn 11, Issue 1, 2007, Pages 36-42

  Yovino, Susannah ^a   Darwin, Peter ^a   Daly, Barry ^a   Garofalo, Michael ^a   Moesinger, Robert ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

Author keywords

CT scan; Endoscopic ultrasound; Pancreatic cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CHI SQUARE DISTRIBUTION; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; PREDICTION AND FORECASTING; RADIOGRAPHY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; ENDOSONOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34250164255     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-007-0110-6     Document Type: Conference Paper

References (17)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995;221(6):721-731.
3. Moertel CG, Frytak S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: the Gastrointestinal Tumor Study Group. Cancer 1981;48(8):1705-1710.
4. Gastrointestinal Tumor Study Group. Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Cancer 1985;56(11):2563-2568.
5. Klaassen DJ, MacIntyre JM, Catton GE, et al. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil - an Eastern Cooperative Oncology Group study. J Clin Oncol 1985;3 (3):373-378.
6. Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 1988;80(10):751-755.
7. Mittal A, Windsor J, Casey P, et al. Matched study of three methods of palliation for malignant pyloroduodenal obstruction. Br J Surg 2004 Feb;91(2):205-209.
8. Maetani I, Tada T, Ukita T, et al. Comparison of duodenal stent placement with surgical gastrojejunostomy for palliation in patients with duodenal obstructions caused by pancreaticobiliary malignancies. Endoscopy 2004 Jan;36(1):73-78.
9. Levy M, Wiersema M EUS-guided celiac plexus neurolysis and celiac plexus block. Gastrointest Endosc 2003;57(7):923-930.
10. Espat N, Brennan MF, Conlon KC. Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass. J Am Coll Surg 1999 Jun;188(6):649-655.
11. Dewitt J, Devereaux B, Chriswell M. et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for diagnosis and staging of pancreatic cancer. Ann Intern Med 2004 Nov 16;141(10):753-763.
12. Ahmad N, Lewis J, Ginsberg G. EUS in preoperative staging of pancreatic cancer. Gastrointest Endosc 2000 Oct;52(4):463-468.
13. Valls C, Andia E, Sanchez A. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR Am J Roentgenol 2002 Apr;178(4):821-826.
14. Fuhrman GM, Charnsangavej C, Abbruzzese JL. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 1994 Jan;167(1):104-111; discussion 111-113.
15. Schlieman MG, Ho HS, Bold RJ. Utility of tumor markers in predicting resectability of pancreatic cancer. Arch Surg 2003 Sep;138(9):951-955.
16. Merchant NB, Conlon KC, Saigo P, et al. Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma. J Am Coll Surg 1999;188(4):421-426.
17. Kelsen DP, Portenoy R, Thaler H, et al. Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery 1997 Jul;122(1):53-59.